SenoVac immuno-senolytic technology
神诺威免疫抗衰技术
Technology
技术
Precision immune clearance begins with the right Seno-antigen.
精准免疫清除，始于正确的Seno-antigen。
We identify surface antigens that distinguish pathological senescent cells, then translate those discoveries into immune-mediated therapeutic strategies designed for selectivity, durable clearance and tissue recovery.
我们发现能够区分病理性衰老细胞的表面抗原，并将这些发现转化为兼顾选择性、持续清除能力与组织修复潜力的免疫治疗策略。
Explore the Science探索科学机制The biological background and our solution
疾病背景与神诺威解决方案
From Senescent Cell Burden to Precision Immune Clearance
从衰老细胞累积到精准免疫清除
Senescent cells accumulate with age and disease, sustaining inflammation, fibrosis and tissue dysfunction. SenoVac identifies selective surface antigens and connects them with immune mechanisms designed to clear pathological cells while preserving healthy tissue.
衰老细胞随年龄与疾病持续累积，推动慢性炎症、纤维化与组织功能损伤。神诺威识别具有选择性的表面抗原，并将其连接至免疫清除机制，在保护健康组织的同时清除病理性衰老细胞。
Senescent Cell Burden Drives Chronic Tissue Damage
衰老细胞累积推动慢性组织损伤
Multiple Routes to Selective Immune Clearance
多路径实现选择性免疫清除
Scientific depth behind the platform
平台背后的科研积累
Science Built for Translation
面向转化的科研平台
SenoVac brings together aging biology, therapeutic-target discovery, multi-context expression evidence and AI-enabled candidate design within one connected research platform.
神诺威将衰老生物学、治疗靶点发现、多场景表达证据与AI辅助候选设计整合于同一科研平台。
This foundation connects biological mechanisms with practical development choices, supports disciplined target evaluation and advances selective immune-clearance strategies toward translation.
这一体系将生物学机制与实际研发选择相连接，支持严谨的靶点评估，并推动选择性免疫清除策略走向转化。